Is your dog depressed? Having trouble letting you go in the morning? Help is on the way.
Eli Lilly said Wednesday it has received approval to market a chewable tablet that calms down dogs who misbehave when separated from their owners.
The Food and Drug Administration has approved Lilly's drug Reconcile to treat the estimated 10.7 million, or 17%, of U.S. dogs that have separation anxiety. According to a company release, dogs that exhibit separation anxiety are prone to "destruction, excess vocalization and inappropriate elimination."
Reconcile is part of a class of antidepressants known as selective serotonin reuptake inhibitors frequently marketed to humans. Lilly's blockbuster depression drug Prozac is one member of the class.
According to Lilly, 73% of dogs treated with the Reconcile showed improved behavior when separated from their owners compared with dogs receiving training alone.